Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EBIT: 2023-2025

Historic EBIT for Incannex Healthcare (IXHL) over the last 2 years, with Sep 2025 value amounting to -$6.8 million.

  • Incannex Healthcare's EBIT fell 8.63% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.3 million, marking a year-over-year increase of 22.51%. This contributed to the annual value of -$23.8 million for FY2025, which is 20.81% up from last year.
  • Per Incannex Healthcare's latest filing, its EBIT stood at -$6.8 million for Q3 2025, which was up 9.75% from -$7.5 million recorded in Q2 2025.
  • Over the past 5 years, Incannex Healthcare's EBIT peaked at -$4.9 million during Q3 2023, and registered a low of -$9.7 million during Q2 2024.
  • Over the past 3 years, Incannex Healthcare's median EBIT value was -$6.8 million (recorded in 2025), while the average stood at -$6.7 million.
  • The largest annual percentage gain for Incannex Healthcare's EBIT in the last 5 years was 37.32% (2024), contrasted with its biggest fall of 27.84% (2024).
  • Incannex Healthcare's EBIT (Quarterly) stood at -$8.0 million in 2023, then spiked by 37.32% to -$5.0 million in 2024, then fell by 8.63% to -$6.8 million in 2025.
  • Its EBIT stands at -$6.8 million for Q3 2025, versus -$7.5 million for Q2 2025 and -$5.0 million for Q1 2025.